Characterization of an mGluR2/3 negative allosteric modulator in rodent models of depression (Q28253233)

1

0 references

Mikhail Kalinichev

2

0 references

Nathalie Lambeng

3

0 references

M El Yacoubi

4

0 references

Isabelle Royer-Urios

5

0 references

Manfred Schneider

6

0 references

Coline Legrand

7

0 references

Delphine Parron

8

0 references

Francoise Girard

9

0 references

Abdelhak Bessif

10

0 references

Sonia Poli

11

0 references

Jean-Marie Vaugeois

12

0 references

Sylvain Celanire

Regulation of neurotransmitter release by metabotropic glutamate receptors

14

0 references

language of work or name

English

0 references

publication date

December 2011

0 references

published in

Journal of Neurogenetics

0 references

volume

25

0 references

issue

4

0 references

page(s)

152-66

0 references

cites work

1 reference

https://api.crossref.org/works/10.3109/01677063.2011.627485

Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons

20 April 2017

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Behavioral characterization of the mGlu group II/III receptor antagonist, LY-341495, in animal models of anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mG

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

G protein-coupled receptor allosterism and complexing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Molecular signalling mediating the protective effect of A1 adenosine and mGlu3 metabotropic glutamate receptor activation against apoptosis by oxygen/glucose deprivation in cultured astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Analysis of allosterism in functional assays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Emerging role of glutamate in the pathophysiology of major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

[3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Locomotor reactivity to a novel environment and sensitivity to MK-801 in five strains of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Allosteric modulators: the new generation of receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

New concepts in drug discovery: collateral efficacy and permissive antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer's amyloid(beta)42 from isolated intact nerve terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Allosteric Modulation of G Protein–Coupled Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Context-dependent pharmacology exhibited by negative allosteric modulators of metabotropic glutamate receptor 7

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

The involvement of glutamate in the pathophysiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Glutamate and depression: clinical and preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Homeostatic regulation of sleep in a genetic model of depression in the mouse: effects of muscarinic and 5-HT1A receptor activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Innovative approaches for the development of antidepressant drugs: current and future strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Pharmacological agents acting at subtypes of metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Blockade of the metabotropic glutamate 2/3 receptors enhances social memory via the AMPA receptor in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Glutamate-based antidepressants: 20 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Genetic epidemiology of major depression: review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

QTL analysis identifies multiple behavioral dimensions in ethological tests of anxiety in laboratory mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 4. In vivo active potent and selective non-competitive metabotropic glutamate receptor 2/3 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Binding of [3H](2S,1'S,2'S)-2-(9-xanthylmethyl)-2-(2'-carboxycyclopropyl) glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

Identification of multiple genetic loci linked to the propensity for "behavioral despair" in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

An mGluR2/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485

The effect of groups II and III metabotropic glutamate receptor activation on neuronal injury in a rodent model of traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01677063.2011.627485